Sanofi SA
Company Profile
Business description
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Contact
46, avenue de la Grande Armée
Paris 75017
FRAT: +33 153774000
E: investor.relations@sanofi.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
87,994
Sanofi SA News & Analysis
stocks
Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?
stocks
10 best US blue-chip shares to buy for the long term
personal-finance
Can you achieve global diversification with multinational companies?
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,150.10 | 129.20 | 1.61% |
| CAC 40 | 8,188.49 | 51.50 | -0.63% |
| DAX 40 | 18,738.81 | 130.55 | -0.69% |
| Dow JONES (US) | 39,992.61 | 84.61 | 0.21% |
| FTSE 100 | 8,438.65 | 7.15 | -0.08% |
| HKSE | 19,376.53 | 302.82 | 1.59% |
| NASDAQ | 16,765.88 | 23.49 | 0.14% |
| Nikkei 225 | 38,920.26 | 534.53 | 1.39% |
| NZX 50 Index | 11,728.06 | 202.18 | 1.75% |
| S&P 500 | 5,317.42 | 9.27 | 0.17% |
| S&P/ASX 200 | 7,881.30 | 127.60 | 1.65% |
| SSE Composite Index | 3,122.40 | 2.50 | 0.08% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.05 | 0.00 | 2.13% |
| Telstra Group Ltd TLS | 3.69 | 0.02 | 0.55% |
| South32 Ltd S32 | 3.75 | 0.08 | 2.18% |
| PYC Therapeutics Ltd PYC | 0.10 | 0.01 | -7.62% |
| Pilbara Minerals Ltd PLS | 4.01 | 0.03 | 0.75% |
| Incitec Pivot Ltd IPL | 2.97 | 0.15 | 5.32% |
| Red 5 Ltd RED | 0.49 | 0.02 | 4.26% |
| Pantoro Ltd PNR | 0.09 | 0.01 | 7.41% |
| Vicinity Centres VCX | 1.98 | 0.05 | 2.60% |
| Mirvac Group MGR | 2.15 | 0.06 | 2.87% |